Skip to main content

A Randomized, Double-Blind, Placebo-Controlled Study of the Safety and Efficacy of Amatuximab in Combination with Pemetrexed and Cisplatin in Subjects with Unresectable Malignant Pleural Mesothelioma

Clinical Trial Grant
Duke Scholars

Administered By

Duke Cancer Institute

Awarded By

Morphotek, Inc

Start Date

April 1, 2016

End Date

April 30, 2016
 

Administered By

Duke Cancer Institute

Awarded By

Morphotek, Inc

Start Date

April 1, 2016

End Date

April 30, 2016